Nebido (Testosterone Undecanoate)

Testosterone undecanoate, the active ingredient in Nebido, is an androgen; anabolic steroid presented as a 1000 mg/4 mL oil solution for intramuscular use. It treats male hypogonadism and testosterone deficiency in adult men and is administered by deep intramuscular injection providing sustained release of testosterone over several weeks.

GNH USA supplies Nebido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebido (testosterone undecanoate) is used in hormone replacement therapy to restore normal testosterone levels.

- Male hypogonadism: restores physiological testosterone concentrations and alleviates symptoms such as low libido, fatigue, and reduced muscle mass. - Testosterone deficiency: supports development of secondary sexual characteristics, improves bone density and mood. - Low testosterone levels: enhances energy, mood, and sexual function in men with clinically confirmed low serum testosterone.

Nebido may cause a range of adverse reactions. The most frequently reported are generally mild and reversible.

Common Side Effects: - Injection site pain or bruising - Swelling or erythema at the injection site - Acne or oily skin - Increased red blood cell count (polycythemia) - Fluid retention or peripheral edema - Headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Significant polycythemia leading to thrombosis - Liver toxicity or elevated liver enzymes - Cardiovascular events such as myocardial infarction - Prostate enlargement or exacerbation of prostate disease - Testicular atrophy or infertility

Before initiating Nebido therapy, clinicians should evaluate several safety parameters.

- Monitor hematocrit: check blood counts regularly to detect polycythemia. - Assess prostate health: perform digital rectal exam and PSA testing. - Evaluate cardiovascular risk: consider history of heart disease or stroke. - Avoid use in patients with known hypersensitivity to testosterone or formulation components. - Use caution in individuals with sleep‑apnea or uncontrolled hypertension. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Nebido can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Warfarin or other oral anticoagulants: increased bleeding risk. - Insulin or oral hypoglycemics: may require dose adjustment due to altered glucose metabolism. - Corticosteroids: can exacerbate fluid retention and hypertension. - 5‑alpha‑reductase inhibitors: may affect androgen metabolism. - GnRH analogues: can blunt the intended hormonal effect.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: monitor blood pressure for additive effects. - Diuretics: watch for electrolyte disturbances. - Lipid‑lowering drugs (statins): monitor liver function. - Antidepressants (SSRIs): observe for mood changes. - Anticonvulsants: may affect testosterone metabolism.